85-1559-43 TREML2, Recombinant, Human (Triggering Receptor Expressed on Monocytes Cells-like Protein 2, TREM-like Transcript 2 Protein, TLT-2, C6orf76, TLT2, UNQ6268/PRO20473) 50ug T8282-40H

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Trem­like transcript 2 protein (TLT­2; also TREML2) is a 33kD (unglycosylated) type I transmembrane cell surface receptor and member of the Trem family of receptor proteins. Human TLT­2 is synthesized as a 321aa precursor that contains an 18 aa signal sequence, a 250aa extracellular domain (ECD), a 21aa transmembrane segment, and a 32aa cytoplasmic tail (SwissProt # Q5T2D2). Within the ECD are an Ig­like V­type domain (aa20­121) and one potential site of N­linked glycosylation. Mature human TLT­2 shares 49% aa sequence identity with mature mouse TLT­2. Cell surface expression of TLT­2 is seen for most of the B and myeloid cell lines. TLT­2 is also expressed constitutively on CD8+ T cells and induced on CD4+ T cells after activation. TLT­2 plays a role in the innate and adaptive immune responses. In 2008, Hashiguchi et al. discovered that the B7 family member B7­H3, which also plays important roles in immune responses, specifically bound to TLT­2. According to their research, stimulation with B7­H3 transfectants preferentially up­regulated the proliferation and IFN-gamma production on CD8+ T cells. Also, transduction of TLT­2 into T cells resulted in enhanced IL­2 and IFN-gamma production via interactions with B7­H3, and blockade of the B7­H3:TLT­2 pathway with mAb against B7­H3 or TLT­2 efficiently inhibited contact hypersensitivity responses. In 2009, however, Leitner et al. extensively analyzed interaction of B7­H3 with TLT­2 and found no evidence for such an interaction.
  • Source:Murine myeloma cell line, NS0­derived Human TREML2 (Gly78-Ser327).
  • SDS-PAGE:75-100kD, reducing conditions
  • Activity:Measured by its ability to inhibit anti­CD3­induced proliferation of stimulated human T cells. Human PBMC cultured for 72 hours with PHA were incubated for an additional 3 days in 96 well plates coated with anti­CD3 and recombinant human TREML2/Fc Chimera. The ED50 for this effect is typically 0.45-1.8ug/ml.
  • Endotoxin Level: ≤1EU/1ug (LAL)
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O or PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:50ug
  • Source Antigen:Recombinant, NS0-derived, murine myeloma cell line
  • Grade:Purified
  • Purity:~90% (SDS-PAGE, reducing conditions)
  • Form:Supplied as a lyophilized powder from PBS. Reconstitute with sterile PBS.
  • Molecular Weight Non Ab:54
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1559-43
型番
T8282-40H
入り数
1個
標準価格
284,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:点

お買い物を続ける カートを見る